American Journal of Therapeutics | 2021

Ivermectin, A Reanalysis of the Data

 
 

Abstract


1. Bryant A, Lawrie TA, Dowswell T, et al. Ivermectin for prevention and treatment of COVID-19 infection: a systematic review, meta-analysis, and trial sequential analysis to inform clinical guidelines. Am J Ther. 2021;28:e434–e460. 2. Roman YM, Burela PA, Pasupuleti V, et al. Ivermectin for the treatment of COVID-19: a systematic review and metaanalysis of randomized controlled trials.,Clin Infect Dis. 2021; ciab591. doi: 10.1093/cid/ciab591. 3. Crawford M. The Meta-Analytical Fixers: An Ivermectin Tale; 2021. Available at: https://roundingtheearth. substack.com/p/the-meta-analytical-fixers-anivermectin. Accessed July 7, 2021. 4. Neil M, Fenton NE, Bayesian Hypothesis Testing and Hierarchical Modelling of Ivermectin Effectiveness in Treating Covid-19, 2021. Available at: http://dx.doi.org/10. 13140/RG.2.2.19703.75680. 5. Niaee MS, Gheibi N, Namdar P, et al. Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: a randomized multi-center clinical trial. Asian Pac J Trop Med. 2021;14:266. 6. Elgazzar A, Hany B, Youssef SA, et al. Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic; 2020. Available at: https://www.researchsquare. com/article/rs-100956/v2.

Volume 28
Pages e579 - e580
DOI 10.1097/MJT.0000000000001443
Language English
Journal American Journal of Therapeutics

Full Text